BONTI, INC.

Profile

Company Names

BONTI, INC.
ENDURANCE BIOTECH, INC.

Addresses

4921 BIRCH ST. SUITE 120, NEWPORT BEACH, CA 92660

4921 BIRCH STREET, SUITE 120, NEWPORT BEACH, CA 92660

747 W. KATELLA AVENUE, SUITE 205, ORANGE, CA 92867

Phone Numbers

949-379-6060
408-219-6984

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$36,009,306.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2018-01-19 
$15,463,786.00 
$15,500,000.00 
$36,214.00 
Equity 
2
2016-12-21 
$11,706,516.00 
$11,850,000.00 
$143,484.00 
Equity 
1
2015-08-03 
$8,839,004.00 
$8,839,004.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KENTON 
BARRY 
ABEL 
EXECUTIVE OFFICER
ENDURANCE BIOTECH, INC.
WAJDIE 
 
AHMAD 
EXECUTIVE OFFICER
ENDURANCE BIOTECH, INC.   |  BONTI, INC.   |  AYA BIOSCIENCES, INC.   |  AMPLIFICA HOLDINGS GROUP, INC.
TOM 
 
ALBRIGHT 
DIRECTOR
BONTI, INC.
LEONARD 
 
BRANDT 
DIRECTOR
ENDURANCE BIOTECH, INC.   |  MIXED-SIGNAL DEVICES INC.
FAUAD 
 
HASAN 
EXECUTIVE OFFICER, DIRECTOR
ENDURANCE BIOTECH, INC.   |  BONTI, INC.   |  AMPLIFICA HOLDINGS GROUP, INC.
DENNIS 
 
HUANG 
DIRECTOR
FOLICA, INC.   |  CIBT EDUCATION GROUP INC.   |  ENDURANCE BIOTECH, INC.   |  BONTI, INC.
MICHAEL 
 
JARPE 
EXECUTIVE OFFICER
ENDURANCE BIOTECH, INC.   |  BONTI, INC.
ALEXEY 
 
KONOV, PH.D. 
DIRECTOR
BONTI, INC.
JONATHAN 
 
LIM, M.D. 
DIRECTOR
BONTI, INC.   |  ERASCA, INC.   |  BOUNDLESS BIO, INC.
DAVID 
 
RAMSAY 
DIRECTOR
ENDURANCE BIOTECH, INC.   |  FORTUNE MINERALS LTD   |  VERMILION GLOBAL MACRO FUND, LP   |  BONTI, INC.   |  F1 ONCOLOGY, INC.   |  EXUMA BIOTECH CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-02-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-19 
2017-04-19
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-21 
2017-01-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-21 
2015-09-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-03 
2015-08-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ASCENDIANT CAPITAL MARKETS, LLC
152912
ASCENDIANT CAPITAL MARKETS, LLC
152912
BRIAN DAVIES
NONE
ASCENDIANT CAPITAL MARKETS, LLC
152912
CHRIS GAYDE
NONE